The c-fos proto-oncogene is a target for transactivation by the p53 tumor suppressor

Molecular and Cellular Biology

Volumn 19, Issue 4, 1999, Pages 2594-2600

  Elkeles, Adi ^a   Juven Gershon, Tamar ^a   Israeli, David ^a   Wilder, Sylvia ^a   Zalcenstein, Amir ^a   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ARTICLE; CANCER; CANCER PREVENTION; GENE INACTIVATION; MOUSE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0032956852     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.4.2594     Document Type: Article

References (53)

1. Angel, P., and M. Karin. 1991. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072:129-157.
2. Barak, Y., T. Juven, R. Haffner, and M. Oren. 1993. mdm2 expression is induced by wild type p53 activity. EMBO J. 12:461-468.
3. Barak, Y., and M. Oren. 1992. Enhanced binding of a 95 kDa protein to p53 in cells undergoing p53-mediated growth arrest. EMBO J. 11:2115-2121.
4. Bates, S., and K. H. Vousden. 1996. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6:12-18.
5. Bourdon, J. C., V. Deguinchambon, J. C. Lelong, P. Dessen, P. May, B. Debuire, and E. May. 1997. Further characterisation of the p53 responsive element - identification of new candidate genes for trans-activation by p53. Oncogene 14:85-94.
6. Buckbinder, L., R. Talbott, M. S. Velasco, I. Takenaka, B. Faha, B. R. Seizinger, and N. Kley. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-649.
7. Canman, C. E., and M. B. Kastan. 1997. Role of p53 in apoptosis. Adv. Pharmacol. 41:429-160.
8. Chen, S. C., T. Curran, and J. I. Morgan. 1995. Apoptosis in the nervous system: new revelations. J. Clin. Pathol. 48:7-12.
9. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 362:849-852.
10. Diatchenko, L., Y. F. Lau, A. P. Campbell, A. Chenchik, F. Moqadam, B. Huang, S. Lukyanov, K. Lukyanov, N. Gurskaya, E. D. Sverdlov, and P. D. Siebert. 1996. Suppression subtractive hybridization: a method fen generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA 93:6025-6030.
11. Dosch, J., and B. Kaina. 1996. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability. Oncogene 13:1927-1935.
12. El-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Gene. 1:45-49.
13. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
14. Elkeles, A., K. M. Devos, D. Graur, M. Zizi, and A. Breiman. 1995. Multiple cDNAs of wheat voltage-dependent anion channels (VDAC): isolation, differential expression, mapping and evolution. Plant Mol. Biol. 29:109-124.
15. Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren. 1991. Wild-type p53 can downmodulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979-9983.
16. Gottlieb, E., R. Haffner, T. Von Ruden, E. F. Wagner, and M. Oren. 1994. Down-regulation of wild-type p53 activity interferes with apoptosis of IL-3-dependent hematopoietic cells following IL-3 withdrawal. EMBO J. 13: 1368-1374.
17. Gottlieb, T. M., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77-102.
18. Guillouf, C., X. Grana, M. Selvakumaran, A. Deluca, A. Giordano, B. Hoffman, and D. A. Liebermann. 1995. Dissection of the genetic programs of p53-mediated G1 growth arrest and apoptosis: blocking p53-induced apoptosis unmasks G1 arrest. Blood 85:2691-2698.
19. Hafezi, F., J. P. Steinbach, A. Marti, K. Munz, Z. Q. Wang, E. F. Wagner, A. Aguzzi, and C. E. Reme. 1997. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat. Med. 3:346-349.
20. Halevy, O., J. Rodel, A. Peled, and M. Oren. 1991. Frequent p53 mutations in chemically-induced murine fibrosarcoma. Oncogene 6:1593-1600.
21. Hansen, R., and M. Oren. 1997. p53; from inductive signal to cellular effect. Curr. Opin. Genet. Dev. 7:46-51.
22. Hermeking, H., C. Lengauer, K. Polyak, T. C. He, L. Zhang, S. Thiagalingam, K. W. Kinzler, and B. Vogelstein. 1997. 14-3-3 σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell 1:3-11.
23. Hollstein, M., T. Soussi, G. Thomas, M. von-Brevern, and H. Bartsch. 1997. p53 gene alterations in human tumors: perspectives for cancer control. Recent Results Cancer Res. 143:369-389.
24. Israeli, D., E. Tessler, Y. Haupt, A. Elkeles, S. Wilder, R. Amsun, A. Telerman, and M. Oren. 1997. A novel p53-inducible gene. PAG608, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J. 16:4384-4392.
25. Johnson, P., S. Chung, and S. Benchimol. 1993. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol. 13:1456-1463.
26. Karin, M., Z. g. Liu, and E. Zandi. 1997. AP-1function and regulation. Curr. Opin. Cell Biol. 9:240-246.
27. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
28. Kley, N., R. Y. Chung, S. Fay, J. P. Loeffler, and B. R. Seizinger. 1992. Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res. 20:4083-4087.
29. Ko, L. J., and C. Prives. 1996. p53: puzzle and paradigm. Genes Dev. 10: 1054-1072.
30. Komarova, E. A., L. Diatchenko, O. W. Rokhlin, J. E. Hill, Z. J. Wang, V. I. Krivokrysenko, E. Feinstein, and A. V. Gudkov. 1998. Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53. Oncogene 17:1089-1096.
31. Lassus, P., M. Ferlin, J. Piette, and U. Hibner. 1996. Anti-apoptotic activity of low levels of wild-type p53. EMBO J. 15:4566-4573.
32. Lehar, S. M., M. Nacht, T. Jacks, C. A. Vater, T. Chittenden, and B. C. Guild. 1996. Identification and cloning of E124, a gene induced by p53 in etoposide-treated cells. Oncogene 12:1181-1187.
33. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
34. Levy, N., E. Yonish-Rouach, M. Oren, and A. Kimchi. 1993. Complementation by wild-type p53 of interleukin-6 effects on M1 cells induction of cell cycle exit and cooperativity with c-myc suppression. Mol. Cell. Biol. 13:7942-7952.
35. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362:847-849.
36. Mitsudomi, T., S. M. Steinberg, M. M. Nau, D. Carbone, D. Damico, S. Bodner, H. K. Oie, R. I. Linnoila, J. L. Mulshine, J. D. Minna, and A. F. Gazdar. 1992. p53 gene mutations is non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene 7:171-180.
37. Miyashita, T., and J. C. Reed. 1995. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293-299.
38. Owen-Schaub, L. B., W. Zhang, J. C. Cusack, L. S. Angelo, S. M. Santee, T. Fujiwara, J. A. Roth, A. B. Deisseroth, W.-W. Zhang, E. Kruzel, and R. Kadinsky. 1995. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell. Biol. 15:3032-3040.
39. Pinhasi-Kimhi, O., D. Michalovitz, and M. Oren. 1986. Specific interaction between the p53 cellular tumor antigen and major heat-shock proteins. Nature 320:182-185.
40. Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
41. Preston, G. A., T. T. Lyon, Y. Yin, J. E. Lang, G. Solomon, L. Annab, D. G. Srinivasan, D. A. Alcorta, and J. C. Barrett. 1996. Induction of apoptosis by c-Fos protein. Mol. Cell. Biol. 16:211-218.
42. Pruschy, M., Y. Q. Shi, N. E. A. Crompton, J. Steinbach, A. Aguzzi, C. Glanzmann, and S. Bodis. 1997. The proto-oncogene c-fos mediates apoptosis in murine T-lymphocytes induced by ionizing radiation and dexamethasone. Biochem. Biophys. Res. Commun. 241:519-524.
43. Rotter, V., R. Aloni-Grinstein, D. Schwartz, N. B. Elkind, A. Simons, R. Wolkowicz, M. Lavigne, P. Beserman, A. Kapon, and N. Goldfinger. 1994. Does wild-type p53 play a role in normal cell differentiation? Semin. Cancer Biol. 5:229-236.
44. Rouault, J. P., N. Falette, F. Guehenneux, C. Guillot, R. Rimokh, Q. Wang, C. Berthet, C. Moyretlalle, P. Savatier, B. Pain, P. Shaw, R. Berger, J. Samarut, J. P. Magaud, M. Ozturk, C. Samarut, and A. Puisieux. 1996. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat. Genet. 14:482-486.
45. Santhanam, U., A. Ray, and P. B. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88:7605-7609.
46. Schreiber, M., B. Baumann, M. Cotten, P. Angel, and E. F. Wagner. 1995. Fos is an essential component of the mammalian UV response. EMBO J. 14: 5338-5349.
47. Smeyne, R. J., M. Vendrell, M. Hayward, S. J. Baker, G. G. Miao, K. Schilling, L. M. Robertson, T. Curran, and J. I. Morgan. 1993. Continuous c-fos expression precedes programmed cell death in vivo. Nature 363:166-169.
48. White, E. 1996. Life, death, and the pursuit of apoptosis. Genes Dev. 10:1-15.
49. Wyllie, A. 1997. Apoptosis - clues in the p53 murder mystery. Nature 389: 237-238.
50. Yin, Y. X., Y. Terauchi, G. G. Solomon, S. Aizawa, P. N. Rangarajan, Y. Yazaki, T. Kadowaki, and J. C. Barrett. 1998. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature 391:707-710.
51. Yonish-Rouach, E., D. Grunwald, S. Wilder, A. Kimchi, E. May, J. J. Lawrence, P. May, and M. Oren. 1993. p53-mediated cell death: relationship to cell cycle control. Mol. Cell. Biol. 13:1415-1423.
52. Yonish-Rouach, E., D. Resnitzky, J. Lotem, L. Sachs, A. Kimchi, and M. Oren. 1991. Wild-type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6. Nature 352:345-347.
53. Zauberman, A., Y. Barak, N. Ragimov, N. Levy, and M. Oren. 1993. Sequence-specific DNA binding by p53: identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J. 12:2799-2808.